Ir para o conteúdo
Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network — TMO EPM / Hemato H9J | Podster